ZOSTAVAX (Varicella zoster vaccine)

Clinical Indication

Prevention of shingles and post-herpetic neuralgia. Live vaccine therefore NOT suitable for immunocompromised patients. Do not prescribe on FP10 (black through this route).


Available centrally from 1st Sept 2013 for those aged 70 and 79 years
Public Health advice

Date of classification

June 2015

Review date

June 2015


Drugs not recommended for use in the Leicestershire Health Community because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.

All new drugs will be black until they have been through the appropriate approval process - then they will appear as a specific entry.